This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Jun;32(6):1201-2.

doi: 10.1097/HJH.0000000000000183.

Are the effects of telmisartan more marked in hypertensive patients?

John Chalmers¹

Affiliations

PMID: 24781511
DOI: 10.1097/HJH.0000000000000183

Editorial

Are the effects of telmisartan more marked in hypertensive patients?

John Chalmers. J Hypertens. 2014 Jun.

. 2014 Jun;32(6):1201-2.

doi: 10.1097/HJH.0000000000000183.

Author

John Chalmers¹

Affiliation

¹ The George Institute for Global Health, University of Sydney and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

PMID: 24781511
DOI: 10.1097/HJH.0000000000000183

No abstract available

PubMed Disclaimer

Comment on

Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: a Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysis.
Foulquier S, Böhm M, Schmieder R, Sleight P, Teo K, Yusuf S, Schumacher H, Unger T. Foulquier S, et al. J Hypertens. 2014 Jun;32(6):1334-41. doi: 10.1097/HJH.0000000000000154. J Hypertens. 2014. PMID: 24621807 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information